These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11079366)

  • 1. Sildenafil causes a dose- and time-dependent downregulation of phosphodiesterase type 6 expression in the rat retina.
    Heywood R; Osterloh IH; Phillips SC
    Int J Impot Res; 2000 Aug; 12(4):241-4. PubMed ID: 11079366
    [No Abstract]   [Full Text] [Related]  

  • 2. The discovery of novel, potent and selective PDE5 inhibitors.
    Bi Y; Stoy P; Adam L; He B; Krupinski J; Normandin D; Pongrac R; Seliger L; Watson A; Macor JE
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2461-4. PubMed ID: 11549447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta.
    Mochida H; Inoue H; Takagi M; Noto T; Yano K; Kikkawa K
    Eur J Pharmacol; 2002 Apr; 440(1):45-52. PubMed ID: 11959087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil causes a dose- and time-dependent downregulation of phosphodiesterase type 6 expression in the rat retina.
    Gonzalez CM; Bervig T; Podlasek C; Huang CF; McKenna KE; McVary KT
    Int J Impot Res; 1999 Sep; 11 Suppl 1():S9-14. PubMed ID: 10554924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.
    Manganiello V
    Mol Pharmacol; 2003 Jun; 63(6):1209-11. PubMed ID: 12761329
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil.
    Gibson A
    Eur J Pharmacol; 2001 Jan; 411(1-2):1-10. PubMed ID: 11137852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism.
    Lin G; Xin ZC; Lue TF; Lin CS
    J Urol; 2003 Aug; 170(2 Pt 2):S15-8; discussion S19. PubMed ID: 12853767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-0156, a novel phosphodiesterase type 5 inhibitor, and sildenafil have different pharmacological effects on penile tumescence and electroretinogram in dogs.
    Mochida H; Noto T; Inoue H; Yano K; Kikkawa K
    Eur J Pharmacol; 2004 Feb; 485(1-3):283-8. PubMed ID: 14757152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of type-5 phosphodiesterase: promising therapy for pulmonary hypertension.
    Watanabe H
    Intern Med; 2004 Oct; 43(10):891-3. PubMed ID: 15575233
    [No Abstract]   [Full Text] [Related]  

  • 10. Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors.
    Wang Y; Chackalamannil S; Hu Z; Boyle CD; Lankin CM; Xia Y; Xu R; Asberom T; Pissarnitski D; Stamford AW; Greenlee WJ; Skell J; Kurowski S; Vemulapalli S; Palamanda J; Chintala M; Wu P; Myers J; Wang P
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3149-52. PubMed ID: 12372521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of sildenafil analogues from anacardic acid and their phosphodiesterase-5 inhibition.
    Paramashivappa R; Phani Kumar P; Subba Rao PV; Srinivasa Rao A
    J Agric Food Chem; 2002 Dec; 50(26):7709-13. PubMed ID: 12475293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds.
    Turko IV; Ballard SA; Francis SH; Corbin JD
    Mol Pharmacol; 1999 Jul; 56(1):124-30. PubMed ID: 10385692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erectile dysfunction: an update on new therapeutic options].
    Roumeguère T
    Acta Urol Belg; 2000; 68(2):41-2. PubMed ID: 11098588
    [No Abstract]   [Full Text] [Related]  

  • 14. Viagra slows the visual response to flicker.
    Stockman A; Sharpe LT; Tufail A; Kell PD; Jeffery G
    Curr Biol; 2006 Jan; 16(2):R44-5. PubMed ID: 16431355
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the sGC stimulator BAY 41-2272 are not mediated by phosphodiesterase 5 inhibition.
    Bischoff E; Stasch JP
    Circulation; 2004 Sep; 110(12):e320-1; author reply e320-1. PubMed ID: 15381669
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of a novel phosphodiesterase type 5 inhibitor: JNJ-10258859.
    Qiu Y; Bhattacharjee S; Kraft P; John TM; Craig E; Haynes-Johnson D; Guan J; Jiang W; Macielag M; Sui Z; Clancy J; Lundeen S
    Eur J Pharmacol; 2003 Jul; 472(1-2):73-80. PubMed ID: 12860475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation.
    Prickaerts J; Sik A; van der Staay FJ; de Vente J; Blokland A
    Psychopharmacology (Berl); 2005 Feb; 177(4):381-90. PubMed ID: 15630588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of T-1032, a novel specific phosphodiesterase type 5 inhibitor, in isolated rat aorta and rabbit corpus cavernosum.
    Takagi M; Mochida H; Noto T; Yano K; Inoue H; Ikeo T; Kikkawa K
    Eur J Pharmacol; 2001 Jan; 411(1-2):161-168. PubMed ID: 11137871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.
    Weimann J; Ullrich R; Hromi J; Fujino Y; Clark MW; Bloch KD; Zapol WM
    Anesthesiology; 2000 Jun; 92(6):1702-12. PubMed ID: 10839922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tachyphylaxis and phosphodiesterase type 5 inhibitors.
    Steers WD
    J Urol; 2002 Jul; 168(1):207. PubMed ID: 12050542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.